1 |
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O. and Landis, R. C. 2004. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte- macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ. Res. 94, 119-126.
DOI
|
2 |
Quimby, K. R., Hambleton, I. R. and Landis, R. C. 2015. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease. Med. Hypotheses 85, 424-432.
DOI
|
3 |
Ratanasopa, K., Chakane, S., Ilyas, M., Nantasenamat, C. and Bulow, L. 2013. Trapping of human hemoglobin by haptoglobin: molecular mechanisms and clinical applications. Antioxid. Redox Signal. 18, 2364-2374.
DOI
|
4 |
Schaer, C. A., Schoedon, G., Imhof, A., Kurrer, M. O. and Schaer, D. J. 2006. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the non-inflammatory and protective transcriptional response of macrophages to hemoglobin. Circ. Res. 99, 943-950.
DOI
|
5 |
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D. and Vercellotti, G. M. 2013. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121, 1276-1284.
DOI
|
6 |
Shen, H., Heuzey, E., Mori, D. N., Wong, C. K., Colangelo, C. M., Chung, L. M., Bruce, C., Slizovskiy, I. B., Booth, C. J., Kreisel, D. and Goldstein, D. R. 2015. Haptoglobin enhances cardiac transplant rejection. Circ. Res. 116, 1670-1679.
DOI
|
7 |
Shen, H., Song, Y., Colangelo, C. M., Wu, T., Bruce, C., Scabia, G., Galan, A., Maffei, M. and Goldstein, D. R. 2012. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J. Clin. Invest. 122, 383-387.
DOI
|
8 |
Wicher, K. B. and Fries, E. 2004. Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein. Proc. Natl. Acad. Sci. USA 101, 14390-14395.
DOI
|
9 |
Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., Antalis, T. M., Vogel, S. N., Zhao, A., Yang, S., Arrietta, M. C., Meddings, J. B. and Fasano, A. 2009. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc. Natl. Acad. Sci. USA 106, 16799-16804.
DOI
|
10 |
Wang, Y., Kinzie, E., Berger, F. G., Lim, S. K. and Baumann, H. 2001. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep. 6, 379-385.
DOI
|
11 |
Wu, J., Zhu, J., Yin, H., Buckanovich, R. J. and Lubman, D. M. 2014. Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay. J. Proteome Res. 13, 2197-2204.
DOI
|
12 |
Zhang, S., Shang, S., Li, W., Qin, X. and Liu, Y. 2016. Insights on N-glycosylation of human haptoglobin and its association with cancers. Glycobiology 26, 684-692.
DOI
|
13 |
Bowman, B. H. and Kurosky, A. 1982. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv. Hum. Genet. 12, 189-261, 453-184.
|
14 |
Zhao, X., Song, S., Sun, G., Strong, R., Zhang, J., Grotta, J. C. and Aronowski, J. 2009. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J. Neurosci. 29, 15819-15827.
DOI
|
15 |
Andersen, C. B., Torvund-Jensen, M., Nielsen, M. J., de Oliveira, C. L., Hersleth, H. P., Andersen, N. H., Pedersen, J. S., Andersen, G. R. and Moestrup, S. K. 2012. Structure of the haptoglobin-haemoglobin complex. Nature 489, 456-459.
DOI
|
16 |
Ang, I. L., Poon, T. C., Lai, P. B., Chan, A. T., Ngai, S. M., Hui, A. Y., Johnson, P. J. and Sung, J. J. 2006. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J. Proteome Res. 5, 2691-2700.
DOI
|
17 |
Arredouani, M., Matthijs, P., Van Hoeyveld, E., Kasran, A., Baumann, H., Ceuppens, J. L. and Stevens, E. 2003. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108, 144-151.
DOI
|
18 |
Arredouani, M. S., Kasran, A., Vanoirbeek, J. A., Berger, F. G., Baumann, H. and Ceuppens, J. L. 2005. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 114, 263-271.
DOI
|
19 |
Galicia, G., Maes, W., Verbinnen, B., Kasran, A., Bullens, D., Arredouani, M. and Ceuppens, J. L. 2009. Haptoglobin deficiency facilitates the development of autoimmune inflammation. Eur. J. Immunol. 39, 3404-3412.
DOI
|
20 |
Cid, M. C., Grant, D. S., Hoffman, G. S., Auerbach, R., Fauci, A. S. and Kleinman, H. K. 1993. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J. Clin. Invest. 91, 977-985.
DOI
|
21 |
Hanley, J. M., Haugen, T. H. and Heath, E. C. 1983. Biosynthesis and processing of rat haptoglobin. J. Biol. Chem. 258, 7858-7869.
|
22 |
Huntoon, K. M., Russell, L., Tracy, E., Barbour, K. W., Li, Q., Shrikant, P. A., Berger, F. G., Garrett-Sinha, L. A. and Baumann, H. 2013. A unique form of haptoglobin produced by murine hematopoietic cells supports B-cell survival, differentiation and immune response. Mol. Immunol. 55, 345-354.
DOI
|
23 |
Kormoczi, G. F., Saemann, M. D., Buchta, C., Peck- Radosavljevic, M., Mayr, W. R., Schwartz, D. W., Dunkler, D., Spitzauer, S. and Panzer, S. 2006. Influence of clinical factors on the haemolysis marker haptoglobin. Eur. J. Clin. Invest. 36, 202-209.
DOI
|
24 |
Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N. and Miyoshi, E. 2006. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808.
DOI
|
25 |
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H. J., Law, S. K. and Moestrup, S. K. 2001. Identification of the haemoglobin scavenger receptor. Nature 409, 198-201.
DOI
|
26 |
Langlois, M. R. and Delanghe, J. R. 1996. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42, 1589-1600.
|
27 |
Levy, A. P., Asleh, R., Blum, S., Levy, N. S., Miller-Lotan, R., Kalet-Litman, S., Anbinder, Y., Lache, O., Nakhoul, F. M., Asaf, R., Farbstein, D., Pollak, M., Soloveichik, Y. Z., Strauss, M., Alshiek, J., Livshits, A., Schwartz, A., Awad, H., Jad, K. and Goldenstein, H. 2010. Haptoglobin: basic and clinical aspects. Antioxid. Redox Signal. 12, 293-304.
DOI
|
28 |
Nagel, R. L. and Gibson, Q. H. 1971. The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J. Biol. Chem. 246, 69-73.
|
29 |
Oh, M. K., Park, H. J., Lee, J. H., Bae, H. M. and Kim, I. S. 2015. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2. FEBS Lett. 589, 1009-1017.
DOI
|
30 |
Park, H. J., Oh, M. K., Kim, N. H., Cho, M. L. and Kim, I. S. 2013. Identification of a specific haptoglobin C-terminal fragment in arthritic synovial fluid and its effect on interleukin- 6 expression. Immunology 140, 133-141.
DOI
|